Press release
Cell Therapy Market Booms with a CAGR of 52% by 2031 Driven by Advances in Regenerative Medicine
Cell Therapy Market Size, Share, Growth Analysis, By Therapy Type(Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others)), By Cell Type(Stem Cell (Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell), By Therapeutic Area(Oncology, Cardiovascular Disease (CVD), Musculoskeletal Disorders, Dermatology), By Region - Industry Forecast 2024-2031Cell Therapy Market [https://www.skyquestt.com/report/cell-therapy-market] size was valued at USD 3.9 Billion in 2022 and is poised to grow from USD 6.7 Billion in 2023 to USD 190.91 Billion by 2031, growing at a CAGR of 52% during the forecast period (2024-2031).
Cell therapy is a procedure that involves replacing damaged or malfunctioning cells with healthy, performing ones. Stem cells are mostly utilized in such sophisticated therapies because of their capacity to develop into specific cells necessary for the restoration of weakened or dysfunctional tissues or cells. Regenerative medicines, which attempt to maintain, improve, or restore cell, tissue, or organ function, employ cell therapy. In addition, cell treatment uses blood, bone marrow, mature, immature, and solid tissue cells, adult stem cells, and embryonic stem cells. The transplanted cells such as induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are essentially classified into two types: autologous cell treatment and non-autologous cell therapy.
Download a detailed overview:
https://www.skyquestt.com/sample-request/cell-therapy-market
Increase in Funding Accelerating Growth of Cell Therapy Market
The increase in funding for cell therapy clinical trials, the development of relevant guidelines for cell therapy manufacturing, and the effectiveness of products are among the primary drivers impacting the market growth. The creation of cell banking facilities, as well as the subsequent rise in cell manufacture, storage, and characterization, has improved the market's global capacity to handle enormous volumes.
Furthermore, many businesses are providing cell therapy characterization research and analysis services, which are advancing the production of cell-based therapies. This has been a major contributor to the market's growing revenue stream over the last few years.
The presence of both private and government financing bodies, which are continually issuing approvals to support projects at various phases of clinical trials, has boosted the clinical trials.Clinical trials have grown as tailored treatment becomes popular. Genetically engineered cell therapies can adapt treatments to each patient's genetics. This tailored analysis transforms healthcare by improving pharmacological efficiency and reducing side effects.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/cell-therapy-market
Increasing Demand for Stem Cell Therapy Owing to Advancements in Automation and Innovative Technologies
Stem cell therapy may cure autoimmune and metabolic diseases, which is increasing its popularity. It is critical in the development of a person's immunity to numerous metabolic diseases. Furthermore, automation in adult stem cell and cord blood processing and storage are essential technologies that are positively impacting the adult and cord blood cell market growth. Umbilical cord blood and tissue are being used to create induced pluripotent stem cells by market leaders.
* June 26, 2023 saw Lonza and Vertex Pharmaceuticals form a strategic partnership. The alliance will help Vertex make its stem cell-derived trial product. This T1D treatment uses completely differentiated insulin-producing islet cells. It will focus on clinically trialed VX-880 and VX-264.
* Janssen Biotech, Inc., a Johnson & Johnson Pharmaceutical Company, announced a global collaboration and license agreement with Cellular Biomedicine Group Inc. on May 2, 2023. (CBMG) to develop, produce, and market next-generation chimeric antigen receptor (CAR) T-cell therapies for curing B-cell malignancies. These investigational CD20-directed autologous CAR-Ts have shown positive and complete response rates in Phase 1 research in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL) in China, with nearly all of those participating had diffuse large B-cell lymphoma (DLBCL), the most prevalent form of aggressive lymphoma, accounting for roughly one-third of all B-cell lymphomas.
* On March 6, 2023, Adaptimmune Therapeutics plc and TCR Therapeutics Inc. merged in an all-stock deal. This will create a leading solid tumor cell therapy company. Through complementary technological platforms, the cooperation enhances clinical development and product delivery. As a result, following the deal, the newly formed company's cash flow is expected to extend until 2026.
* On May 27, 2022, the Food and Drug Administration provided accelerated approval to tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) for adult patients suffering from relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. he multicenter, single-arm, open-label ELARA trial was used to approve tisagenlecleucel, a CD19-directed CAR T cell treatment, for relapsed adult patients.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/cell-therapy-market
Replacement, repair, restoration, and regeneration of wounded tissues and organs are possible using cell-based therapies. Researchers are investing substantially in developing such efficient and secure medicines as alternatives to traditional treatment procedures, which is expected to drive market expansion. The expanding number of clinical trials for cell-based therapeutics is propelling the cell therapy market. As a result, investments in research and clinical translation have also increased significantly. The presence of government and commercial funding entities that are constantly providing funds to projects at various stages of clinical trials can be connected to the increasing number of clinical studies. Furthermore, improvements in regenerative medicine are expected to result in improved treatment options for chronic diseases.
Related Reports:
Electric Vehicle (EV) Market [https://www.skyquestt.com/report/electric-vehicle-market]
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cell-therapy-market-booms-with-a-cagr-of-52-by-2031-driven-by-advances-in-regenerative-medicine]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/cell-therapy-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Therapy Market Booms with a CAGR of 52% by 2031 Driven by Advances in Regenerative Medicine here
News-ID: 3556802 • Views: …
More Releases from ABNewswire

Best Deals on Billie Eilish 2025 Tour Tickets - Use Promo Code CITY10 at Capital …
Get the best deals on Billie Eilish 2025 tour tickets at CapitalCityTickets.com. Fans can secure seats to her highly anticipated shows at unbeatable prices by shopping online. Use promo code CITY10 at checkout to save even more on already discounted tickets. Don't miss the chance to experience Billie's electrifying performances live while keeping your budget in check. CapitalCityTickets.com is your trusted source for affordable concert tickets nationwide.
Are you ready to…

New York Real Estate Lawyer Peter Zinkovetsky Outlines Key Qualities Buyers and …
In the fast-paced world of New York City real estate, having the guidance of a qualified New York real estate lawyer can significantly affect the outcome of a property transaction. At Avenue Law Firm, founding attorney Peter Zinkovetsky (https://www.avenuelawfirm.com/what-makes-good-real-estate-lawyer/) focuses on supporting clients through complex legal procedures, helping ensure that contracts, disclosures, and closings are completed accurately and efficiently.
Legal representation from a New York real estate lawyer becomes essential when…

Accounting & Bookkeeping Services of IBN Technologies Enhance U.S. Healthcare Pr …
IBN Technologies offers HIPAA-compliant accounting & bookkeeping services for U.S. healthcare providers. From managing reimbursements and claims to vendor payments and payroll, their expert team ensures financial accuracy, compliance, and efficiency. Practices gain clear reporting, reduced back-office burden, and stronger operational control across all locations.
Miami, Florida, 11 Sep 2025 One of the most complex and regulated sectors of the American economy is the financial operations of healthcare practices. Accurate accounting…

IBN Technologies' Online Accounting & Bookkeeping Services Assist U.S. E-Commerc …
IBN Technologies delivers cloud-based bookkeeping for U.S. e-commerce brands, reducing costs, improving accuracy, and simplifying tax prep. With real-time insights, daily reconciliations, and virtual assistant support, sellers scale faster while staying financially compliant. Trusted by 1,500+ online retailers nationwide.
Miami, Florida, 11 Sep 2025 Navigating a rapidly evolving environment of digital storefronts, order fulfillment, marketing expenditures, and tax requirements is part of operating an e-commerce business in the United States. Maintaining…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…